IL2 and hyperthyroidism: In group C, four participants withdrew during Step I because of intolerance to IL-2 injections, one withdrew during Step II because he/she wanted to restart HAART, two were terminated because of the development of hyperthyroidism, and one was terminated because of low CD4+ T cell concentrations.